Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL
Clinical trial NCT03305445 · COMPLETED
Trial details
- NCT number
- NCT03305445
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2021-04-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.